Coverage of: Poulikakos, P.I., Persaud, Y., Janakiraman, M. et al. (2011) RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 480, 387–390. Li, Y., Alsagabi, M., Fan, D., Bova, G.S., Tewfik, A.H., Dehm, S.M. (2011) Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression. Cancer Res 71, 2108–2117. Li, Y., Hwang, T.H., Oseth, L.A., Hauge, A., Vessella, R.L., Schmechel, S.C., Hirsch, B., Beckman, K.B., Silverstein, K.A., Dehm, S.M. (2012) AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression. Oncogene [Epub ahead of print, DOI: 10.1038/onc.2011.637].
NEWS AND VIEWS
Therapy resistance by splicing: can the androgen receptor teach us about BRAF?
Version of Record online: 17 APR 2012
© 2012 John Wiley & Sons A/S
Pigment Cell & Melanoma Research
Volume 25, Issue 3, pages 293–294, May 2012
How to Cite
Qi, J. (2012), Therapy resistance by splicing: can the androgen receptor teach us about BRAF?. Pigment Cell & Melanoma Research, 25: 293–294. doi: 10.1111/j.1755-148X.2012.01000.x
- Issue online: 17 APR 2012
- Version of Record online: 17 APR 2012
- Accepted manuscript online: 21 MAR 2012 10:09AM EST